SmallCap
CompaniesStatistics

(주)에니바이오

Venture Certified
Data Quality: 8/10

Basic Information


Unlisted

Company Name(주)에니바이오
Business Reg. No.3828702046
CEO박명금
Address대전광역시 유성구
Industry화장품 제조업
Industry Code20423
Main Products입욕제,암염골드앰플,salt'Q
EstablishedContact
Phone042-933-****
WebsiteContact
Regular EmployeesContact
Corp. Reg. No.160111-*******

Investment Metrics


Market Cap
-
Op. Margin
10.08%
ROE
47.19%
Debt Ratio
149.68%

Certification Status


Venture Certified

Cert. History
혁신성장유형2022-06-22 ~ 2025-06-2120220622030015-
혁신성장유형2025-06-22 ~ 2028-06-21202507160300772025-07-16

Financial Statements


3-Year Financial Data

Revenue CAGR +21.6%

Item202420232022
Revenue

3.5B

3.3B

2.4B

Operating Profit

0.4B

-0.4B

-0.1B

Net Profit

0.5B

0.0B

0.0B

Total Assets

2.5B

5.1B

2.0B

Total Liabilities

1.5B

4.6B

1.5B

Total Equity

1.0B

0.5B

0.5B

Comparison Metrics


vs. 3-Year Avg.
Based on 2024
Revenue
4B

24.3%

vs. 3-Year Avg.: 3B
Operating Profit
357910K

236.4%

vs. 3-Year Avg.: -262510K
Op. Margin
10.1%

220.5%

vs. 3-Year Avg.: -8.4%
Debt Ratio
149.7%

73.6%

vs. 3-Year Avg.: 567.4%
ROE
47.2%

2435.2%

vs. 3-Year Avg.: 1.9%

Officers / Major Shareholders


Only CEO info available (unlisted company)
NamePositionRole
박명금대표이사대표

Employment Status


Regular EmployeesContact
CEO박명금

Patent Status

Updated: 2026-02-25

No Data Contact

No patents found or data not yet available.

Procurement Record

Updated: 2026-02-25

No Data Contact

No procurement record or data not yet available

Support Programs


No Data Contact

No matching support programs for this industry

Tax / Business Status

Updated: 2026-02-25

Business Status: active
Tax Type부가가치세 일반과세자

SME Status


Venture
Status

Cert. flags confirmed (details update after further collection)

Other Public Data


1 Additional Data Sources

{
  "address": "대전광역시 유성구",
  "ceo_name": "박명금",
  "certificate": [
    {
      "cert_number": "20220622030015",
      "changes": "",
      "disclosure_date": "2022-06-22",
      "first_cert_date": "",
      "no": "1",
      "type": "혁신성장유형",
      "valid_period": "2022-06-22 ~ 2025-06-21"
    },
    {
      "cert_number": "20250716030077",
      "changes": "",
      "disclosure_date": "2025-07-16",
      "first_cert_date": "2025-07-16",
      "no": "2",
      "type": "혁신성장유형",
      "valid_period": "2025-06-22 ~ 2028-06-21"
    }
  ],
  "company_name": "(주)에니바이오",
  "corp_no": "160111-*******",
  "financials": {
    "2022": {
      "capital_stock": 50000000,
      "cost_of_sales": 100585000,
      "current_assets": 57810000,
      "current_liabilities": 146673000,
      "gross_profit": 139515000,
      "net_income": 1372000,
      "net_income_bs": 1193000,
      "non_current_assets": 141840000,
      "non_current_liabilities": 0,
      "non_operating_expenses": 0,
      "non_operating_income": 9115000,
      "operating_profit": -7743000,
      "revenue": 240100000,
      "sga_expenses": 147258000,
      "total_assets": 199650000,
      "total_equity": 52977000,
      "total_liabilities": 146673000
    },
    "2023": {
      "capital_stock": 50000000,
      "cost_of_sales": 124306000,
      "current_assets": 371481000,
      "current_liabilities": 459738000,
      "gross_profit": 206917000,
      "net_income": 607000,
      "net_income_bs": 607000,
      "non_current_assets": 141840000,
      "non_current_liabilities": 0,
      "non_operating_expenses": 3300000,
      "non_operating_income": 48657000,
      "operating_profit": -44750000,
      "revenue": 331223000,
      "sga_expenses": 251667000,
      "total_assets": 513321000,
      "total_equity": 53584000,
      "total_liabilities": 459738000
    },
    "2024": {
      "capital_stock": 50000000,
      "cost_of_sales": 187832000,
      "current_assets": 139451000,
      "current_liabilities": 150540000,
      "gross_profit": 167125000,
      "net_income": 47459000,
      "net_income_bs": 46990000,
      "non_current_assets": 111663000,
      "non_current_liabilities": 0,
      "non_operating_expenses": 4797000,
      "non_operating_income": 16465000,
      "operating_profit": 35791000,
      "revenue": 354957000,
      "sga_expenses": 131334000,
      "total_assets": 251114000,
      "total_equity": 100574000,
      "total_liabilities": 150540000
    }
  },
  "industry": "화장품 제조업",
  "investment": [],
  "main_products": "입욕제,암염골드앰플,salt'Q",
  "phone": "042-933-****",
  "years": [
    2024,
    2023,
    2022
  ]
}

Data Sources


Data Quality: 8/10 | Primary Source: Venture System | Section Coverage: 7/8

Data Sources by Section
SectionSource:Status
Basic InfoPublic Data
Collected
Financial StatementsVenture System
Collected
Investment MetricsVenture System
Collected
OfficersPublic Data
Collected
EmploymentNot Collected
Not Collected
CertificationsPublic Data
Collected
PatentsKIPRIS
Collected
ProcurementG2B Procurement
Collected
Collected API Sources
APICollectedStatus
G2B Procurement2026-02-25
Collected
Employment Insurance2026-02-25
Collected
KIPRIS Patents2026-02-25
Collected
HomeTax Business2026-02-25
Collected
Venture System Detail2026-02-25
Collected